Cardiac-targeted rAAV5-S100A1 gene therapy protects against adverse remodeling and contractile dysfunction in post-ischemic hearts https://www.biorxiv.org/content/10.1101/2023.03.03.529004v1?med=mas
Cardiac-targeted rAAV5-S100A1 gene therapy protects against adverse remodeling and contractile dysfunction in post-ischemic hearts https://www.biorxiv.org/content/10.1101/2023.03.03.529004v1?med=mas